首页|粪便隐血试验在体检人群中对大肠癌早期筛查的价值

粪便隐血试验在体检人群中对大肠癌早期筛查的价值

扫码查看
目的 研究免疫化学法粪便隐血试验(FIT)在体检人群中大肠癌早期筛查的应用价值。方法 选取2017年9月至2020年9月该院体检中心健康体检人群,收集行FIT患者的基本资料,根据内镜下有无新生物、FIT检测值、新生物直径及位置进行分组;采用单样本K-S检验、Kruskal-Wallis H检查、x2检验进行组间统计分析,Spearman法分析双变量关系,多重线性回归模型分析性别、年龄及新生物病理类型、位置、直径、个数对FIT的预测价值。结果 315例患者满足FIT>100 ng/mL并完成肠镜检查,包括大肠癌(腺癌)19例,腺瘤性息肉94例,增生性息肉59例,正常及其他疾病143例,男性大肠癌发病比率高于女性(x2=15。74,P<0。01)。FIT检测值平均中位水平:肿瘤组>腺瘤性息肉组>无新生物组>增生性息肉组,除无新生物组与增生性息肉组之间差异无统计学意义(P=0。206),其余各组间差异均有统计学意义(P<0。05)。随着FIT检测值的增加,肠镜正常和增生性息肉的占比下降,腺瘤和腺癌的占比升高(P<0。01)。新生物直径中位水平:肿瘤组>腺瘤性息肉组>增生性息肉组(P<0。01)。随着新生物直径的增加,增生性息肉百分比下降,肿瘤所占比例增加(P<0。01)。左半结肠发病率显著高于结肠其他部位(P<0。01)。双变量相关分析显示,FIT检测值与新生物病理类型、直径、个数呈正相关(r=0。291、0。591、0。354,P<0。01)。多重线性回归分析显示新生物病理类型、直径、个数是影响FIT检测值的独立影响因素,线性方程式为Y=-584。875+319。315× 1+264。241 ×2+109。942 × 3(× 1、× 2、× 3分别代表新生物病理类型、直径、个数),P<0。01。结论 FIT能够有效应用于大肠癌的早期筛查,其检测值高低与肠道新生物癌变程度、直径呈正相关,男性患者、左半结肠病变、大直径新生物易发生癌变。
Value of fecal occult blood test for early screening of colorectal cancer among people undergoing physical examination
Objective To investigate the application value of fecal occult blood immunochemical test(FIT)for early screening of colorectal cancer(CRC)among physical examination population.Methods The healthy people undergoing physical examination in this hospital from September 2017 to September 2020 were selected.The basic data in the subjects with FIT were collected.The subjects were grouped according to whether having neoplasm,FIT detection value,neoplasm diameter and position.The single sample K-S test,Kruskal-Wallis H test and Chi-square test were used for inter-group statistical analysis.The Spearman test was used to analyze the two-variable relationship,and the multi-linear regression model was used to analyze the predictive value of sex,age,neoplasm pathological type,location,diameter and number for FIT.Results A total of 315 patients met FIT>100 ng/mL and completed the colonoscopic examination,including 19 cases of colorectal cancer(adenocarcinoma),94 cases of adenomatous polyps,59 cases of hyperplastic polyps,and 143 cases of normality and other diseases.The incidence rate of colorectal cancer in men was higher than that in women(X2=15.74,P<0.01).The average median level of FIT detection values:adenocarcinoma group>ad-enomatous polyp group>non-neoplasm group>hyperplastic polyp group,there was statatistically significant difference among the other groups except the difference between the non-neoplasm group and hyperplastic pol-yp group had no statistical significance(P<0.05).With the increase of FIT detection level,the proportion of enteroscopic normality and hypertrophic polyps was decreased,and the proportion of adenoma and adenocarci-noma was increased.The median level of neoplasm diameter:tumor group>adenomatous polyp group>hy-perplastic polyp group(P<0.01).With the neoplasm diameter increase,the percentage of hyperplastic polyps was decreased and the proportion of tumors was increased.The incidence rate of left hemi-colon was signifi-cantly higher than that of other parts of the colon(P<0.01).The two-variable correlation analysis showed that the FIT detection value was positively correlated with the pathologic type,diameter and number of neo-plasm(r=0.291,0.591,0.354,P<0.01).The multi-linear regression analysis showed that the pathologic type,diameter and number of neoplasm were the independent influencing factors affecting the FIT detection value,and the linear equation was Y=-584.875+319.315X1+264.241X2+109.942 X3(X1,X 2,X 3 re-present the pathologic type,diameter,number respectively).Conclusion FIT can be effectively applied to ear-ly screening of colorectal cancer,and its detection value is positively correlated with the canceration degree and diameter of intestinal tract neoplasm,and the male patients,left hemi-colon and large diameter neoplasm are more likely to have canceration.

Colorectal cancerFecal occult blood testEarly screeningPhysical examination

罗林飞、李洪、黄紫庆

展开 >

南昌大学第二附属医院消化科,江西南昌 330000

大肠癌 粪便隐血试验 早期筛查 体检

江西省卫生健康委员会科技计划项目

202130498

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(1)
  • 23